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Summary of the impact
Since the 1990s therapeutic procedures 
using catheters, stents and other minimal-
ly invasive medical devices have replaced 
the need for invasive surgical procedures of 
the past. However, many of these devices 
are made of metal alloys which are diffi-
cult to see during treatment. The Materials 
and Surface Science Institute (MSSI) at the 
University of Limerick has invented a new 
alloy that overcomes this difficulty. Medical 
devices made from this new alloy will be 
highly visible under medical x-ray imaging, 
making placement, manipulation and ap-
plication inside the body much easier. This 
will significantly improve treatment quality 
by reducing time required for treatment, 
repeat procedures, and trauma. In addition 
to impacting patients, the project has sig-
nificantly increased medical R&D capacity 
in Ireland and helped provide highly skilled 
jobs in both research and manufacturing. 
The research was conducted by UL in part-
nership with international medical devices 
company Cook Medical, and was support-
ed by Enterprise Ireland.
Underpinning research
Many medical devices, such as stents and 
valves placed in the body through minimal-
ly invasive surgical procedures, significantly 
reduce patient trauma and hospitalisation 
time. These procedures are usually carried 
out with the help of some kind of medical 
imaging, such as X-ray fluoroscopy, so that 
the surgeon can see clearly where the de-
vice is placed. Binary Nitinol (NiTi) is used 
extensively in medical devices due to its 
super-elasticity and shape memory, both of 
which are critical in placing medical devic-
es. The limitation of NiTi is it has poor radi-
opacity; that is, it is not easily visible under 
X-ray. This problem becomes even more 
acute when the size of the medical device 
becomes smaller. 
Up to now many companies have used 
gold or platinum to modify existing alloys; 
these substances improve radiopacity but 
are very expensive. The solution has been 
to mark devices with a narrow band or 
other type of marker. However, X-ray visi-
ble markers are a less than optimal solu-
tion, since they do not allow the surgeon 
to visualise the whole device as it is being 
placed. The ideal solution would be a de-
vice that was fully visible under the X-ray; 
the challenge for the UL-Cook team was 
to develop a radiopaque material based on 
the currently approved alloys for medical 
devices, at a cost significantly lower than 
gold or platinum.
Using first principle modelling and predic-
tive materials design, the UL-Cook team 
found a patentable solution: alloying NiTi 
with one of the rare earth elements that 
would be more radiopaque than the plat-
inum currently added to NiTi as a marker 
band. This solution transcends common 
understanding of some of the established 
laws of physics and improves the radiovisi-
bility of NiTi by over 80%. The solution adds 
5-10% more radiopacity than platinum to 
NiTi, is 15 times cheaper than adding plat-
inum, and retains NiTi’s shape memory and 
superelastic properties within an accept-
able range for medical device application. 
UL and Cook worked in a highly collabo-
rative, flexible way throughout the project 
(2005-2013). UL’s project design kept scal-
ability and competitiveness of manufacture 
as their central focus. On their part, Cook 
understood that fundamental research is 
critical in developing a completely new 
product, and engaged with UL at a level 
that is uncommon in an academic/business 
partnership. The UL-Cook team was put 
to test when the original project plan was 
completely overhauled, giving UL responsi-
bility not only for the design and testing of 
the alloy, but also for laboratory scale de-
velopments, for which critical infrastructure 
did not exist in Ireland and had to be devel-
oped by the UL research team.  The team 
was further challenged when the nature of 
the new alloy forced them to seek a num-
ber of alternative strategies for making and 
processing the alloy (Ref 1). 
The UL-Cook team met all the challeng-
es associated with developing a complete 
new alloy system: learning and mastering 
methods to suit new infrastructure (such as 
spark plasma sintering, commissioned in UL 
in December 2008); developing both con-
ventional and custom-built infrastructure 
(such as hot and cold metal-rolling bench-
es and an isothermal metal extruder); and 
solving materials-related problems (such as 




hot shortness, interdendritic segregation, 
and surface crack propagation). The team’s 
success was built on excellent communi-
cation, collaboration, openness to out-of-
the-box solutions, ability to assess risk, and 
steadfastness in implementing contingency 
plans.
The facilities and expertise developed in UL 
during the project resulted in a novel pow-
der metallurgy process to replace conven-
tional induction melting, which had proven 
less viable for producing this new alloy. In 
February 2013, the team demonstrated a 
prototype radiopaque NiTiEr wire; the tech-
nology is scalable and has been transferred 
to Cook for device development. 
In short, the new alloy developed by the 
UL-Cook team will make medical devices 
fully visible under X-ray, in a cost-effective 
way. The project provides a stellar example 
of industry-academia collaboration that 
produces breakthrough innovations with 
potential worldwide benefits.
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Details of the impact
Clinical impact
Patient trauma and hospitalisation time 
have been significantly reduced by medical 
devices such as stents and valves which can 
be placed in the body through minimally 
invasive surgical procedures; an estimated 
1 million stents are placed annually in the 
USA alone.  However, high X-ray visibility 
is critical during surgery to ensure exact 
placement of these devices while keeping 
the patient’s X-ray exposure to a minimum. 
Radiopaque NiTi will significantly enhance 
the visibility of these devices by 80-100%, 
providing ease of placement, minimising 
patients’ trauma during deployment, and 
significantly reducing the radiation dose 
received by a patient in his lifetime. The 
availability of such metals will allow physi-
cians to fully visualise the devices they are 
manipulating within the body. This will sig-
nificantly reduce errors in device handling 
and placing, improving medical outcomes 
for patients.
Economic impact
The global market for minimally inva-
sive surgical devices is estimated to reach 
the level of €17 billion - €26 billion in 
2015/20161. Therefore, the market oppor-
tunity for a superelastic alloy with fluro-
scopic visibility is very significant. “Tests on 
a prototype wire of the newly developed 
alloy have shown its potential for use in a 
number of Cook products. The fact that the 
raw materials are more viable than the plat-
inum added solutions also means that the 
commercialisation potential of this newly 
developed alloy is very high.” (Source 2)
Cook Medical is the largest privately owned 
medical device manufacturer in the world, 
with a worldwide workforce of over 10,000. 
Its Limerick plant employs around 800 
people; it is the European distribution cen-
tre for Cook products, and the worldwide 
manufacturer of Cook’s ZilverTM Stent. The 
development of this new radiopaque alloy 
is strategically important for the Irish plant 
as further R&D responsibility has transferred 
into Ireland as a result of this successful 
technology development. In 2013, Cook 
Medical Ireland announced the establish-
ment of its state-of-the-art R&D facility in 
Limerick. (Source 3 and 8). Cook Medical 
Ireland added a dedicated research team 
to support a large number of industry/ac-
ademia projects. This project demonstrates 




for research in Ireland and is now a funda-
mental part of the Cook Research structure. 
Technical Innovation Impact
The project produced technical impact in 
the field of medical device manufacture 
by developing a cheaper alternative to 
platinum that enhances radiopacity of the 
whole device, allowing far greater visibility 
than a localised solution such as a marker 
band. In addition, the project has generat-
ed 2 granted patents (1 US and 1 European) 
(Ref 3 & 4) and 20 other pending patents, 
and delivered a prototype wire.  Most im-
portantly, it has produced a completely 
new ternary alloy system and solved a pro-
cessing problem that had forced metallur-
gists to preclude rare earth elements as an 
alloying option to NiTi.
Professor Noel O’Dowd, Director of UL’s 
Materials and Surface Science Institute 
(MSSI), notes that the project builds on MS-
SI’s experience in developing new materials 
for industrial applications. “MSSI’s materi-
als design and processing capability and 
state-of-the-art infrastructure for materials 
characterisation have been critical in devel-
oping this ground-breaking alloy. The suc-
cess of this research shows a high return on 
investment made by the Irish government, 
both on commercialisation of research and 
the research infrastructure.”
Academic/Industry Impact
This research endeavour has increased UL’s 
capacity to partner with industry in ways 
that produce impact far beyond the cam-
pus. Bill Doherty, Executive Vice President 
of Cook Medical for Europe, Middle East 
and Africa and Managing Director of the 
Irish operation, expressed his delight on the 
success of the partnership between Cook 
and UL; “This project is a good example of 
the strength of UL in translational research 
where research strongly impacts the in-
dustrial community. Building on Enterprise 
Ireland’s support, UL and Cook’s ability to 
work closely together will be extremely 
helpful in implementing this breakthrough 
technology into commercial products that 
benefit patients worldwide”. (Source 4)
The 8 year project created a pipeline of 
students between academia and industry, 
affording extraordinary professional devel-
opment opportunities to young scientists 
and allowing for the quick transfer of deep 
knowledge acquired through experience 
(Source 10). The core team supported four 
completed PhD theses; one of the PhD 
graduates has joined Cook as an employee 
and two continue to work in UL as post-
doctoral researchers dedicated to projects 
directly funded by Cook. The project also 
provided multiple-year employment for six 
postdoctoral fellows and one research as-
sistant while one postdoctoral fellow was 
offered a permanent position at Cook. The 
research has laid the foundation for a UL-
Cook research portfolio of over €2 million 
within CÚRAM, the medical device research 
centre funded by Science Foundation Ire-
land. In brief, the project has allowed both 
UL and Cook Medical to showcase the 
breadth and depth of R&D capabilities avail-
able in Ireland. 
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Sources of impact and outputs are limited 
due to the proprietary nature of the tech-
nology at present. 
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